KESKİN, Z. Et Al. 2023. Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line. Cumhuriyet Science Journal , vol.44, no.4 , 635-639.

KESKİN, Z., YULAK, F., TERZİ, H., & İNANIR, M., (2023). Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line. Cumhuriyet Science Journal , vol.44, no.4, 635-639.

KESKİN, ZEKERİYA Et Al. "Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line," Cumhuriyet Science Journal , vol.44, no.4, 635-639, 2023

KESKİN, ZEKERİYA Et Al. "Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line." Cumhuriyet Science Journal , vol.44, no.4, pp.635-639, 2023

KESKİN, Z. Et Al. (2023) . "Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line." Cumhuriyet Science Journal , vol.44, no.4, pp.635-639.

@article{article, author={ZEKERİYA KESKİN Et Al. }, title={Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line}, journal={Cumhuriyet Science Journal}, year=2023, pages={635-639} }